As of 2026-08-28, VEON Ltd. (VEON) trades at $60.40 against an EvidInvest fair-value range of $75.36–$364 (base estimate $201), built from 4 independent valuation methods on filed financial statements. The market price is 70% below the base estimate, so the models read the stock as undervalued. Research, not investment advice.
Download the full VEON valuation report (PDF) — free
DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.
Interpretation
PEG = P/E ÷ Annual EPS Growth Rate (%). Peter Lynch's growth-adjusted value metric.
Interpretation
EV/EBITDA = Enterprise Value ÷ EBITDA. Capital-structure neutral — preferred by professional investors.
Interpretation
P/S = Market Cap ÷ Revenue. Useful for growth/unprofitable companies. SaaS/high-growth norms higher.
Less meaningful for Communication Services
Interpretation
P/B = Price ÷ Book Value per Share. Essential for banks, REITs, and asset-heavy companies.
430.1% premium vs current price
Interpretation
√(22.5 × EPS × Book Value/Share) — Benjamin Graham's intrinsic value estimate.
61.2% vs current price ($60.40)
✅ Competitive advantage likely
Greenwald EPV assumes zero future growth — this is the floor value of the business as a going concern.